星空体育官方入口网站网址大全-登录入口官网

#FTD#

7篇内容 | 927人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1515378, encodeId=b3dc15153e8c2, content=<a href='/topic/show?id=9acce69980' target=_blank style='color:#2F92EE;'>#FTD#</a>, objectTitle=Gastric Cancer：III期TAGS研究不同年龄亚组分析Trifluridine and tipiracil (曲氟尿苷替匹嘧啶，FTD/TPI)治疗经治转移性胃/胃食管交界处癌(mGC/GEJC)患者的疗效和安全性, objectType=article, longId=293627, objectId=c7ac29362eb8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7ac29362eb8, replyNumber=0, likeNumber=42, createdTime=2022-01-10, rootId=0, userName=jingyanzhu715_39486104, userId=c06c10776539, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7ac29362eb8, moduleTitle=Gastric Cancer：III期TAGS研究不同年龄亚组分析Trifluridine and tipiracil (曲氟尿苷替匹嘧啶，FTD/TPI)治疗经治转移性胃/胃食管交界处癌(mGC/GEJC)患者的疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c7ac29362eb8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515377, encodeId=d19415153e74e, content=<a href='/topic/show?id=9acce69980' target=_blank style='color:#2F92EE;'>#FTD#</a>, objectTitle=Front Oncol：原发性肿瘤位置(PTL)对于mCRC患者后线使用REG或FTD/TPI治疗的影响, objectType=article, longId=219546, objectId=ba20219546f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba20219546f3, replyNumber=0, likeNumber=53, createdTime=2021-11-01, rootId=0, userName=jingyanzhu715_39486104, userId=c06c10776539, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba20219546f3, moduleTitle=Front Oncol：原发性肿瘤位置(PTL)对于mCRC患者后线使用REG或FTD/TPI治疗的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ba20219546f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515376, encodeId=bde715153e66d, content=<a href='/topic/show?id=9acce69980' target=_blank style='color:#2F92EE;'>#FTD#</a>, objectTitle=The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比, objectType=article, longId=218080, objectId=e0d821808039, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0d821808039, replyNumber=0, likeNumber=60, createdTime=2021-10-05, rootId=0, userName=jingyanzhu715_39486104, userId=c06c10776539, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0d821808039, moduleTitle=The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e0d821808039)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515375, encodeId=127215153e528, content=<a href='/topic/show?id=9acce69980' target=_blank style='color:#2F92EE;'>#FTD#</a>, objectTitle=Clin cancer res：FTD/TPI+伊立替康+贝伐单抗联合治疗晚期消化道肿瘤的疗效和安全性, objectType=article, longId=191573, objectId=25001915e376, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25001915e376, replyNumber=0, likeNumber=64, createdTime=2020-04-08, rootId=0, userName=jingyanzhu715_39486104, userId=c06c10776539, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25001915e376, moduleTitle=Clin cancer res：FTD/TPI+伊立替康+贝伐单抗联合治疗晚期消化道肿瘤的疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=25001915e376)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515374, encodeId=b2fc15153e406, content=<a href='/topic/show?id=9acce69980' target=_blank style='color:#2F92EE;'>#FTD#</a>, objectTitle=FTD（TAS-102）后线治疗晚期胃癌疗效与安全性并优, objectType=article, longId=168155, objectId=2445168155ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2445168155ce, replyNumber=0, likeNumber=68, createdTime=2019-06-13, rootId=0, userName=jingyanzhu715_39486104, userId=c06c10776539, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2445168155ce, moduleTitle=FTD（TAS-102）后线治疗晚期胃癌疗效与安全性并优, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2445168155ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515373, encodeId=3ab615153e36c, content=<a href='/topic/show?id=9acce69980' target=_blank style='color:#2F92EE;'>#FTD#</a>, objectTitle=Science：科学家发现ALS和FTD等神经退行性疾病病因, objectType=article, longId=51219, objectId=8e0751219cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e0751219cd, replyNumber=0, likeNumber=74, createdTime=2015-05-28, rootId=0, userName=jingyanzhu715_39486104, userId=c06c10776539, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e0751219cd, moduleTitle=Science：科学家发现ALS和FTD等神经退行性疾病病因, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8e0751219cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515372, encodeId=0e6015153e2f1, content=<a href='/topic/show?id=9acce69980' target=_blank style='color:#2F92EE;'>#FTD#</a>, objectTitle=J Neurosci：提振谷氨酸受体恢复FTD小鼠的突触功能, objectType=article, longId=43831, objectId=cd8d4383164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd8d4383164, replyNumber=0, likeNumber=58, createdTime=2014-12-12, rootId=0, userName=jingyanzhu715_39486104, userId=c06c10776539, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd8d4383164, moduleTitle=J Neurosci：提振谷氨酸受体恢复FTD小鼠的突触功能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cd8d4383164)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FTD

2020-05-29

jingyanzhu715_39486104 (审核中...)

前往app查看评论内容

#FTD#

Gastric Cancer：III期TAGS研究不同年龄亚组分析Trifluridine and tipiracil (曲氟尿苷替匹嘧啶，FTD/TPI)治疗经治转移性胃/胃食管交界处癌(mGC/GEJC)患者的疗效和安全性

2022-01-10

jingyanzhu715_39486104 (审核中...)

前往app查看评论内容

#FTD#

Front Oncol：原发性肿瘤位置(PTL)对于mCRC患者后线使用REG或FTD/TPI治疗的影响

2021-11-01

jingyanzhu715_39486104 (审核中...)

前往app查看评论内容

#FTD#

The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比

2021-10-05

jingyanzhu715_39486104 (审核中...)

前往app查看评论内容

#FTD#

Clin cancer res：FTD/TPI+伊立替康+贝伐单抗联合治疗晚期消化道肿瘤的疗效和安全性

2020-04-08

jingyanzhu715_39486104 (审核中...)

前往app查看评论内容

#FTD#

FTD（TAS-102）后线治疗晚期胃癌疗效与安全性并优

2019-06-13

jingyanzhu715_39486104 (审核中...)

前往app查看评论内容

#FTD#

Science：科学家发现ALS和FTD等神经退行性疾病病因

2015-05-28

jingyanzhu715_39486104 (审核中...)

前往app查看评论内容

#FTD#

J Neurosci：提振谷氨酸受体恢复FTD小鼠的突触功能

2014-12-12

科室
- - 订阅+
  - 更多科室
工具
服务